Annual EBIT
-$643.30 M
-$461.60 M-254.05%
31 December 2023
Summary:
Emergent BioSolutions annual earnings before interest & taxes is currently -$643.30 million, with the most recent change of -$461.60 million (-254.05%) on 31 December 2023. During the last 3 years, it has fallen by -$1.09 billion (-245.15%). EBS annual EBIT is now -245.15% below its all-time high of $557.70 million.EBS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$150.70 M
+$396.90 M+161.21%
30 September 2024
Summary:
Emergent BioSolutions quarterly earnings before interest & taxes is currently $150.70 million, with the most recent change of +$396.90 million (+161.21%) on 30 September 2024. Over the past year, it has increased by +$396.90 million (+161.21%). EBS quarterly EBIT is now -43.39% below its all-time high of $266.20 million, reached on 31 December 2020.EBS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$91.90 M
+$396.90 M+81.20%
30 September 2024
Summary:
Emergent BioSolutions TTM earnings before interest & taxes is currently -$91.90 million, with the most recent change of +$396.90 million (+81.20%) on 30 September 2024. Over the past year, it has increased by +$567.20 million (+86.06%). EBS TTM EBIT is now -116.72% below its all-time high of $549.60 million, reached on 31 March 2021.EBS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -254.1% | +161.2% | +86.1% |
| 3 y3 years | -245.2% | +506.2% | -127.1% |
| 5 y5 years | -803.8% | +117.8% | -295.5% |
EBS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -245.2% | at low | -43.2% | +161.2% | -127.1% | +86.1% |
| 5 y | 5 years | -245.2% | at low | -43.4% | +161.2% | -116.7% | +86.1% |
| alltime | all time | -245.2% | at low | -43.4% | +161.2% | -116.7% | +86.1% |
Emergent BioSolutions EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $150.70 M(-161.2%) | -$91.90 M(-81.2%) |
| June 2024 | - | -$246.20 M(-776.4%) | -$488.80 M(+5.3%) |
| Mar 2024 | - | $36.40 M(-211.0%) | -$464.20 M(-27.8%) |
| Dec 2023 | -$643.30 M(+254.0%) | -$32.80 M(-86.7%) | -$643.30 M(-2.4%) |
| Sept 2023 | - | -$246.20 M(+11.1%) | -$659.10 M(+39.8%) |
| June 2023 | - | -$221.60 M(+55.3%) | -$471.60 M(+45.1%) |
| Mar 2023 | - | -$142.70 M(+193.6%) | -$325.00 M(+82.7%) |
| Dec 2022 | -$181.70 M(-153.8%) | -$48.60 M(-17.2%) | -$177.90 M(-230.8%) |
| Sept 2022 | - | -$58.70 M(-21.7%) | $136.00 M(-13.7%) |
| June 2022 | - | -$75.00 M(-1804.5%) | $157.60 M(-36.6%) |
| Mar 2022 | - | $4.40 M(-98.3%) | $248.40 M(-26.4%) |
| Dec 2021 | $337.70 M(-23.8%) | $265.30 M(-815.1%) | $337.70 M(-0.3%) |
| Sept 2021 | - | -$37.10 M(-334.8%) | $338.60 M(-22.7%) |
| June 2021 | - | $15.80 M(-83.1%) | $438.30 M(-20.3%) |
| Mar 2021 | - | $93.70 M(-64.8%) | $549.60 M(+24.0%) |
| Dec 2020 | $443.20 M(+282.7%) | $266.20 M(+325.2%) | $443.20 M(+72.0%) |
| Sept 2020 | - | $62.60 M(-50.7%) | $257.60 M(-2.5%) |
| June 2020 | - | $127.10 M(-1100.8%) | $264.20 M(+100.9%) |
| Mar 2020 | - | -$12.70 M(-115.8%) | $131.50 M(+13.4%) |
| Dec 2019 | $115.80 M(+26.7%) | $80.60 M(+16.5%) | $116.00 M(+146.8%) |
| Sept 2019 | - | $69.20 M(-1335.7%) | $47.00 M(<-9900.0%) |
| June 2019 | - | -$5.60 M(-80.1%) | -$100.00 K(-100.1%) |
| Mar 2019 | - | -$28.20 M(-343.1%) | $72.30 M(-20.8%) |
| Dec 2018 | $91.40 M(-27.0%) | $11.60 M(-47.5%) | $91.30 M(-31.1%) |
| Sept 2018 | - | $22.10 M(-66.9%) | $132.49 M(-16.5%) |
| June 2018 | - | $66.80 M(-826.1%) | $158.69 M(+58.0%) |
| Mar 2018 | - | -$9.20 M(-117.4%) | $100.42 M(-19.8%) |
| Dec 2017 | $125.20 M(+17.2%) | $52.79 M(+9.3%) | $125.20 M(+0.9%) |
| Sept 2017 | - | $48.30 M(+466.6%) | $124.03 M(+11.4%) |
| June 2017 | - | $8.53 M(-45.3%) | $111.33 M(+10.2%) |
| Mar 2017 | - | $15.58 M(-69.8%) | $101.00 M(-5.4%) |
| Dec 2016 | $106.80 M(-24.9%) | $51.62 M(+45.0%) | $106.80 M(-10.9%) |
| Sept 2016 | - | $35.60 M(-2079.0%) | $119.92 M(-19.0%) |
| June 2016 | - | -$1.80 M(-108.4%) | $148.10 M(-13.5%) |
| Mar 2016 | - | $21.38 M(-67.0%) | $171.13 M(+40.7%) |
| Dec 2015 | $142.24 M(+53.9%) | $64.74 M(+1.5%) | $121.63 M(-8.9%) |
| Sept 2015 | - | $63.78 M(+200.5%) | $133.50 M(+31.9%) |
| June 2015 | - | $21.23 M(-175.5%) | $101.22 M(+13.5%) |
| Mar 2015 | - | -$28.13 M(-136.7%) | $89.21 M(-3.5%) |
| Dec 2014 | $92.43 M(+116.0%) | $76.61 M(+143.1%) | $92.43 M(+137.6%) |
| Sept 2014 | - | $31.51 M(+242.0%) | $38.90 M(+51.5%) |
| June 2014 | - | $9.21 M(-137.0%) | $25.68 M(-17.7%) |
| Mar 2014 | - | -$24.91 M(-207.9%) | $31.21 M(-27.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $42.80 M(+33.5%) | $23.08 M(+26.2%) | $42.80 M(-2.8%) |
| Sept 2013 | - | $18.29 M(+24.1%) | $44.01 M(+23.7%) |
| June 2013 | - | $14.74 M(-210.7%) | $35.58 M(+16.9%) |
| Mar 2013 | - | -$13.31 M(-154.8%) | $30.43 M(-5.1%) |
| Dec 2012 | $32.07 M(+0.4%) | $24.29 M(+146.5%) | $32.08 M(-40.1%) |
| Sept 2012 | - | $9.86 M(+2.8%) | $53.55 M(+18.6%) |
| June 2012 | - | $9.59 M(-182.2%) | $45.16 M(-19.0%) |
| Mar 2012 | - | -$11.66 M(-125.5%) | $55.76 M(+74.5%) |
| Dec 2011 | $31.94 M(-56.5%) | $45.76 M(+3019.4%) | $31.95 M(+50.9%) |
| Sept 2011 | - | $1.47 M(-92.7%) | $21.17 M(-46.2%) |
| June 2011 | - | $20.19 M(-156.9%) | $39.34 M(+14.6%) |
| Mar 2011 | - | -$35.47 M(-201.4%) | $34.34 M(-53.2%) |
| Dec 2010 | $73.37 M(+76.7%) | $34.98 M(+78.1%) | $73.37 M(+71.1%) |
| Sept 2010 | - | $19.64 M(+29.3%) | $42.88 M(+117.4%) |
| June 2010 | - | $15.19 M(+327.0%) | $19.72 M(-28.4%) |
| Mar 2010 | - | $3.56 M(-20.8%) | $27.53 M(-33.7%) |
| Dec 2009 | $41.52 M(+29.5%) | $4.49 M(-227.6%) | $41.52 M(+3.8%) |
| Sept 2009 | - | -$3.52 M(-115.3%) | $40.02 M(-32.0%) |
| June 2009 | - | $23.00 M(+31.1%) | $58.87 M(+50.6%) |
| Mar 2009 | - | $17.54 M(+487.3%) | $39.08 M(+17.1%) |
| Dec 2008 | $32.06 M(-3.1%) | $2.99 M(-80.5%) | $33.36 M(-54.6%) |
| Sept 2008 | - | $15.34 M(+377.4%) | $73.53 M(+17.4%) |
| June 2008 | - | $3.21 M(-72.8%) | $62.62 M(+23.4%) |
| Mar 2008 | - | $11.83 M(-72.6%) | $50.75 M(+53.4%) |
| Dec 2007 | $33.09 M(-14.1%) | $43.16 M(+876.0%) | $33.09 M(-2.2%) |
| Sept 2007 | - | $4.42 M(-151.1%) | $33.83 M(-14.6%) |
| June 2007 | - | -$8.66 M(+48.5%) | $39.61 M(-43.6%) |
| Mar 2007 | - | -$5.83 M(-113.3%) | $70.21 M(-28.3%) |
| Dec 2006 | $38.51 M(-19.6%) | $43.90 M(+330.5%) | $97.99 M(+548.7%) |
| Sept 2006 | - | $10.20 M(-53.5%) | $15.11 M(-55.4%) |
| June 2006 | - | $21.95 M(0.0%) | $33.87 M(-17.2%) |
| Mar 2006 | - | $21.95 M(-156.3%) | $40.89 M(-14.6%) |
| Dec 2005 | $47.91 M(+269.9%) | -$38.99 M(-234.6%) | $47.91 M(+28.7%) |
| Sept 2005 | - | $28.97 M(0.0%) | $37.23 M(+27.8%) |
| June 2005 | - | $28.97 M(0.0%) | $29.14 M(+38.5%) |
| Mar 2005 | - | $28.97 M(-158.3%) | $21.05 M(+62.5%) |
| Dec 2004 | $12.95 M(-76.8%) | -$49.67 M(-337.9%) | $12.95 M(-79.3%) |
| Sept 2004 | - | $20.87 M(0.0%) | $62.62 M(+50.0%) |
| June 2004 | - | $20.87 M(0.0%) | $41.75 M(+100.0%) |
| Mar 2004 | - | $20.87 M | $20.87 M |
| Dec 2003 | $55.77 M(+47.7%) | - | - |
| Dec 2002 | $37.77 M(-16.6%) | - | - |
| Dec 2001 | $45.31 M | - | - |
FAQ
- What is Emergent BioSolutions annual earnings before interest & taxes?
- What is the all time high annual EBIT for Emergent BioSolutions?
- What is Emergent BioSolutions annual EBIT year-on-year change?
- What is Emergent BioSolutions quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly EBIT year-on-year change?
- What is Emergent BioSolutions TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Emergent BioSolutions?
- What is Emergent BioSolutions TTM EBIT year-on-year change?
What is Emergent BioSolutions annual earnings before interest & taxes?
The current annual EBIT of EBS is -$643.30 M
What is the all time high annual EBIT for Emergent BioSolutions?
Emergent BioSolutions all-time high annual earnings before interest & taxes is $557.70 M
What is Emergent BioSolutions annual EBIT year-on-year change?
Over the past year, EBS annual earnings before interest & taxes has changed by -$461.60 M (-254.05%)
What is Emergent BioSolutions quarterly earnings before interest & taxes?
The current quarterly EBIT of EBS is $150.70 M
What is the all time high quarterly EBIT for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly earnings before interest & taxes is $266.20 M
What is Emergent BioSolutions quarterly EBIT year-on-year change?
Over the past year, EBS quarterly earnings before interest & taxes has changed by +$396.90 M (+161.21%)
What is Emergent BioSolutions TTM earnings before interest & taxes?
The current TTM EBIT of EBS is -$91.90 M
What is the all time high TTM EBIT for Emergent BioSolutions?
Emergent BioSolutions all-time high TTM earnings before interest & taxes is $549.60 M
What is Emergent BioSolutions TTM EBIT year-on-year change?
Over the past year, EBS TTM earnings before interest & taxes has changed by +$567.20 M (+86.06%)